K.N. Chi

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events

Mitchell R. Smith, Robert E. Coleman, Laurence Klotz et al. · Annals of Oncology · 2014 · 145 citations · Full text

Medicine, Oncology, Bone Metabolism +16

A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer

K.N. Chi, Susan Ellard, Sebastién J. Hotte et al. · Annals of Oncology · 2007 · 118 citations · Full text

Medicine, Oncology, Urology +13

A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131

Karen A. Gelmon, Doug Stewart, K.N. Chi et al. · Annals of Oncology · 2004 · 20 citations

Medicine, Oncology, Pharmacotherapy +7